However, when the granzyme secretion was evaluated as a ratio between plasmatic granzymes A and B (granzyme ratio), it was found that non-hospitalized COVID-19 patients presented a higher granzyme ratio than severe patients: 114.7 (53.9–271.2) vs. 37.5 (27.9–62.7), p = 0.013 (Figure 3A). This evidence concerns the gene GZMA and COVID-19.